Investors flee emerging markets
Emerging markets saw net outflows of about $30bn last month, as investors took fright.
Investors are souring on emerging markets. The asset class saw net outflows of about $30bn last month, says Edward Glossop of Capital Economics – the biggest outflow since the turmoil of March. Their caution is understandable, says Yen Nee Lee on CNBC. From Brazil to India, emerging markets are host to some of the world’s worst coronavirus outbreaks.
Yet some markets remain in favour. Take China, South Korea and Taiwan, where exporters are cashing in on the “upswing in the tech cycle” and the virus remains under control, says Ben Powell of asset manager BlackRock. Investors’ growing pickiness is especially evident in debt markets, says Jonathan Wheatley in the Financial Times. Chinese government bonds attracted $89bn through the end of August; a ten-year bond at 3% per year evidently looks like a great deal to buyers. By contrast, the 7.3% yield on offer in Brazil has far fewer takers, with $9bn being pulled from Brazilian government bond markets this year.
Value hunters will find a “panoply of bargains” in emerging markets, with stocks trading at “less than half the average price-to-book ratio” of US peers and offering generous yields, says Craig Mellow in Barron’s. Yet the coming months are likely to be rocky. For those with the stomach to bet on a “catch-up run”, Brazil looks “the best candidate”. The market has plunged this year but solid fiscal support and tax reforms could yet spark a rally.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Sign up to Money Morning
Our team, led by award winning editors, is dedicated to delivering you the top news, analysis, and guides to help you manage your money, grow your investments and build wealth.
Alex Rankine is Moneyweek's markets editor
-
Higher rates are disappearing – should you fix your savings?
Fixed savings rates have dropped to their lowest levels in over a year. Should you fix your savings now ahead of a potential base rate cut in November?
By Katie Williams Published
-
Nine million people fall victim to financial scams, says Citizens Advice
The charity says that around one in five people across the UK have been caught out by a finance scam in the past year - here is how to protect your money
By Chris Newlands Published
-
What will a broken-up Google look like?
The US courts have ruled that Google is a monopoly, leaving it facing the prospect of a break-up. WIll that be a good thing?
By Matthew Lynn Published
-
How will the UK gambling sector be hit by the Budget?
There are concerns for the UK gambling sector in the lead-up to the Autumn Budget. What could be on the cards?
By Dr Matthew Partridge Published
-
HSBC returns to cost-cutting plan
HSBC is set to revamp its commercial banking division – but will it come at a cost?
By Dr Matthew Partridge Published
-
Pfizer shares rise as US investor takes $1 billion stake
Pfizer shares are on the up since US activist investor Starboard Value built up a stake in the drug maker. But strategic options appear limited
By Dr Matthew Partridge Published
-
Qualcomm could acquire rival Intel – but securing the deal won't be easy
A tie-up between Qualcomm and its semiconductor rival Intel would be a coup. But multiple regulatory and commercial hurdles lie ahead.
By Dr Matthew Partridge Published
-
Modi’s reforms set Indian stocks on fire
Indian stocks pass a new milestone, but global fund managers are holding back. Are there signs of overheating?
By Alex Rankine Published
-
How to invest in the quiet market months
Here's how to invest in the quiet market months, since “sell in May” hasn’t paid off this year.
By Cris Sholto Heaton Published
-
Spire Healthcare: invest in the booming demand for private healthcare
Spire Healthcare is one of the few listed companies benefiting from the growing trend in private healthcare. Should you invest?
By Rupert Hargreaves Published